A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*

标题
A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*
作者
关键词
-
出版物
CRITICAL CARE MEDICINE
Volume 37, Issue 6, Pages 1874-1880
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2009-05-22
DOI
10.1097/ccm.0b013e31819fff2c

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now